Repetitive transcranial magnetic stimulation over the dorsolateral prefrontal cortex for treating posttraumatic stress disorder: An exploratory meta-analysis of randomized, double-blind and sham-controlled trials

Canadian Journal of Psychiatry

Volumn 59, Issue 9, 2014, Pages 487-496

  Berlim, Marcelo T ^a,b   Van Den Eynde, Frederique ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

Acceptability; Efficacy; Meta analysis; Posttraumatic stress disorder; Randomized controlled trials; Repetitive transcranial magnetic stimulation

Indexed keywords

ANXIETY; ASSAULT; BATTLE INJURY; DEPRESSION; DISEASE SEVERITY; EMOTION; FEAR; HUMAN; KIDNAPPING; LIFE THREAT; META ANALYSIS; OCCUPATIONAL ACCIDENT; POSTTRAUMATIC STRESS DISORDER; PREFRONTAL CORTEX; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEXUAL ABUSE; SYMPTOM; TRAFFIC ACCIDENT; TRANSCRANIAL MAGNETIC STIMULATION; ADULT; FEMALE; MALE; MIDDLE AGED; PATHOLOGY; PATIENT ATTITUDE; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STRESS DISORDERS, POST-TRAUMATIC; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84907189925     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371405900905     Document Type: Review

References (79)

1. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593-602.
2. Kessler RC, Sonnega A, Bromet E, et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52:1048-1060.
3. Bisson JI. Post-traumatic stress disorder. BMJ. 2007;334:789-793.
4. Stein DJ, Seedat S, Iversen A, et al. Post-traumatic stress disorder: medicine and politics. Lancet. 2007;369:139-144.
5. Brunello N, Davidson JR, Deahl M, et al. Posttraumatic stress disorder: diagnosis and epidemiology, comorbidity and social consequences, biology and treatment. Neuropsychobiology. 2001;43:150-162.
6. Solomon SD, Davidson J.R. Trauma: prevalence, impairment, service use, and cost. J Clin Psychiatry. 1997;58(Suppl 9):5-11.
7. Ipser JC, Stein DJ. Evidence-based pharmacotherapy of posttraumatic stress disorder (PTSD). Int J Neuropsychopharmacol. 2012;15:825-840.
8. Ponniah K, Hollon SD. Empirically supported psychological treatments for adult acute stress disorder and posttraumatic stress disorder: a review. Depress Anxiety. 2009;26:1086-1109.
9. Van Etten ML, Taylor S. Comparative efficacy of treatment for posttraumatic stress disorder: a meta-analysis. Clin Psychol Psychother. 1998;5:126-144.
10. Novakovic V, Sher L, Lapidus KA, et al. Brain stimulation in posttraumatic stress disorder. Eur J Psychotraumatol. 2011;2. doi: 10.3402/ejpt.v2i0.5609. Epub 2011 Oct 17.
11. George MS, Post RM. Daily left prefrontal repetitive transcranial magnetic stimulation for acute treatment of medication-resistant depression. Am J Psychiatry. 2011;168:356-364.
12. Rosa MA, Lisanby S.H. Somatic treatments for mood disorders. Neuropsychopharmacology. 2012;37:102-116.
13. Berlim MT, Van den Eynde F, Perdomo ST, et al. Response, remission and dropout rates following high frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med. 2014;44:225-239.
14. Slotema CW, Aleman A, Daskalakis ZJ, et al. Meta-analysis of repetitive transcranial magnetic stimulation in the treatment of auditory verbal hallucinations: update and effects after one month. Schizophr Res. 2012;142:40-45.
15. Patel R, Spreng RN, Shin LM, et al. Neurocircuitry models of posttraumatic stress disorder and beyond: a meta-analysis of functional neuroimaging studies. Neurosci Biobehav Rev. 2012;36:2130-2142.
16. Hayes JP, Hayes SM, Mikedis AM. Quantitative meta-analysis of neural activity in posttraumatic stress disorder. Biol Mood Anxiety Disord. 2012;2:9.
17. Etkin A, Wager TD. Functional neuroimaging of anxiety: a metaanalysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry. 2007;164:1476-1488.
18. Moore SA. Cognitive abnormalities in posttraumatic stress disorder. Curr Opin Psychiatry. 2009;22:19-24.
19. McNally RJ. Cognitive abnormalities in post-traumatic stress disorder. Trends Cogn Sci. 2006;10:271-277.
20. Vanderhasselt MA, De Raedt R, Baeken C, et al. The influence of rTMS over the right dorsolateral prefrontal cortex on intentional set switching. Exp Brain Res. 2006;172:561-565.
21. Wagner M, Rihs TA, Mosimann UP, et al. Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex affects divided attention immediately after cessation of stimulation. J Psychiatr Res. 2006;40:315-321.
22. Osaka N, Otsuka Y, Hirose N, et al. Transcranial magnetic stimulation (TMS) applied to left dorsolateral prefrontal cortex disrupts verbal working memory performance in humans. Neurosci Lett. 2007;418:232-235.
23. Sandrini M, Rossini PM, Miniussi C. Lateralized contribution of prefrontal cortex in controlling task-irrelevant information during verbal and spatial working memory tasks: rTMS evidence. Neuropsychologia. 2008;46:2056-2063.
24. Turriziani P, Smirni D, Oliveri M, et al. The role of the prefrontal cortex in familiarity and recollection processes during verbal and non-verbal recognition memory: an rTMS study. Neuroimage. 2010;52:348-357.
25. Hwang JH, Kim SH, Park CS, et al. Acute high-frequency rTMS of the left dorsolateral prefrontal cortex and attentional control in healthy young men. Brain Res. 2010;1329:152-158.
26. Vanderhasselt MA, De Raedt R, Leyman L, et al. Acute effects of repetitive transcranial magnetic stimulation on attentional control are related to antidepressant outcomes. J Psychiatry Neurosci. 2009;34:119-126.
27. van't Wout M, Kahn RS, Sanfey AG, et al. Repetitive transcranial magnetic stimulation over the right dorsolateral prefrontal cortex affects strategic decision-making. Neuroreport. 2005;16:1849-1852.
28. Philiastides MG, Auksztulewicz R, Heekeren HR, et al. Causal role of dorsolateral prefrontal cortex in human perceptual decision making. Curr Biol. 2011;21:980-983.
29. McCann UD, Kimbrell TA, Morgan CM, et al. Repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Arch Gen Psychiatry. 1998;55:276-279.
30. Grisaru N, Amir M, Cohen H, et al. Effect of transcranial magnetic stimulation in posttraumatic stress disorder: a preliminary study. Biol Psychiatry. 1998;44:52-55.
31. Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010;71:992-999.
32. Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004;161:515-524.
33. Watts BV, Landon B, Groft A, et al. A sham controlled study of repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Brain Stimul. 2012;5:38-43.
34. Rosenberg PB, Mehndiratta RB, Mehndiratta YP, et al. Repetitive transcranial magnetic stimulation treatment of comorbid posttraumatic stress disorder and major depression. J Neuropsychiatry Clin Neurosci. 2002;14:270-276.
35. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. 1st ed. West Sussex (GB): John Wiley & Sons Ltd; 2008.
36. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed. Washington (DC): APA; 1994.
37. World Health Organization (WHO). The ICD-10 Classi?cation of Mental and Behavioural Disorders: clinical descriptions and diagnostic guidelines. 10th ed. Geneva (CH): WHO; 1992.
38. Davidson JR, Colket JT. The eight-item treatment-outcome posttraumatic stress disorder scale: a brief measure to assess treatment outcome in post-traumatic stress disorder. Int Clin Psychopharmacol. 1997;12:41-45.
39. Wilkins KC, Lang AJ, Norman SB. Synthesis of the psychometric properties of the PTSD checklist (PCL) military, civilian, and specific versions. Depress Anxiety. 2011;28:596-606.
40. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50-55.
41. Kendall PC, Finch AJ Jr, Auerbach SM, et al. The State-Trait Anxiety Inventory: a systematic evaluation. J Consult Clin Psychol. 1976;44:406-412.
42. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
43. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
44. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12.
45. Boutron I, Guittet L, Estellat C, et al. Reporting methods of blinding in randomized trials assessing nonpharmacological treatments. PLoS Med. 2007;4:e61.
46. Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. BMJ. 2011;342:d549.
47. Fergusson D, Aaron SD, Guyatt G, et al. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ. 2002;325:652-654.
48. Rosenthal R. Meta-analytic procedures for social research. Newbury Park (CA): Sage Publications; 1993.
49. Furukawa TA, Barbui C, Cipriani A, et al. Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol. 2006;59:7-10.
50. Borenstein M, Hedges LV, Higgins JPT, et al. Introduction to metaanalysis. West Sussex (GB): Wiley & Sons Ltd; 2009.
51. Grissom RJ, Kim JJ. Effect sizes for research - univariate and multivariate application. New York (NY): Routledge; 2012.
52. Cooper H, Hedges LV, Valentine JC. The handbook of research synthesis and meta-analysis. New York (NY): Russell Sage Foundation Publications; 2009.
53. Rosenthal R. The file drawer problem and tolerance for null results. Psychol Bull. 1979;86:638-641.
54. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
55. Rothstein HR, Sutton AJ, Borenstein M. Publication bias in metaanalysis: prevention, assessment and adjustments. 1st ed. London (GB): John Wiley & Sons Ltd; 2005.
56. Hoogendam JM, Ramakers GM, Di Lazzaro V. Physiology of repetitive transcranial magnetic stimulation of the human brain. Brain Stimul. 2010;3:95-118.
57. Bestmann S. The physiological basis of transcranial magnetic stimulation. Trends Cogn Sci. 2008;12:81-83.
58. Iyer MB, Schleper N, Wassermann EM. Priming stimulation enhances the depressant effect of low-frequency repetitive transcranial magnetic stimulation. J Neurosci. 2003;23:10867-10872.
59. Touge T, Gerschlager W, Brown P, et al. Are the after-effects of low-frequency rTMS on motor cortex excitability due to changes in the efficacy of cortical synapses? Clin Neurophysiol. 2001;112:2138-2145.
60. Weisz N, Steidle L, Lorenz I. Formerly known as inhibitory: effects of 1-Hz rTMS on auditory cortex are state-dependent. Eur J Neurosci. 2012;36:2077-2087.
61. Daskalakis ZJ, Moller B, Christensen BK, et al. The effects of repetitive transcranial magnetic stimulation on cortical inhibition in healthy human subjects. Exp Brain Res. 2006;174:403-412.
62. Pare D, Duvarci S. Amygdala microcircuits mediating fear expression and extinction. Curr Opin Neurobiol. 2012;22:717-723.
63. Mahan AL, Ressler KJ. Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder. Trends Neurosci. 2012;35:24-35.
64. Kim MJ, Loucks RA, Palmer AL, et al. The structural and functional connectivity of the amygdala: from normal emotion to pathological anxiety. Behav Brain Res. 2011;223:403-410.
65. Shin LM, Handwerger K. Is posttraumatic stress disorder a stressinduced fear circuitry disorder? J Trauma Stress. 2009;22:409-415.
66. Powers MB, Halpern JM, Ferenschak MP, et al. A meta-analytic review of prolonged exposure for posttraumatic stress disorder. Clin Psychol Rev. 2010;30:635-641.
67. Pae CU, Lim HK, Peindl K, et al. The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebocontrolled clinical trials. Int Clin Psychopharmacol. 2008;23:1-8.
68. Peterchev AV, Wagner TA, Miranda PC, et al. Fundamentals of transcranial electric and magnetic stimulation dose: definition, selection, and reporting practices. Brain Stimul. 2012;5:435-453.
69. George MS, Aston-Jones G. Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS). Neuropsychopharmacology. 2010;35:301-316.
70. Matthews PM, Honey GD, Bullmore ET. Applications of fMRI in translational medicine and clinical practice. Nat Rev Neurosci. 2006;7:732-744.
71. Khodayari-Rostamabad A, Reilly JP, Hasey GM, et al. Using pre-treatment electroencephalography data to predict response to transcranial magnetic stimulation therapy for major depression. Conf Proc IEEE Eng Med Biol Soc. 2011;2011:6418-6421.
72. Isserles M, Shalev AY, Roth Y, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder - a pilot study. Brain Stimul. 2013; 6(3):377-383. doi: 10.1016/j.brs.2012.07.008. Epub 2012 Aug 18.
73. Huang Y-Z, Edwards MJ, Rounis E, et al. Theta burst stimulation of the human motor cortex. Neuron. 2005;45:201-206.
74. Rossi S, Hallett M, Rossini PM, et al. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120:2008-2039.
75. Berlim MT, Broadbent H, Van den Eynde F. Blinding integrity in clinical trials of high frequency repetitive transcranial magnetic stimulation (rTMS) for depression: a meta-analysis. Int J Neuropsychopharmacol. 2013;16(5):1173-1181. doi: 10.1017/S1461145712001691. Epub 2013 Feb 11.
76. Schonfeldt-Lecuona C, Lefaucheur JP, Cardenas-Morales L, et al. The value of neuronavigated rTMS for the treatment of depression. Neurophysiol Clin. 2010;40:37-43.
77. Wassermann EM, Zimmermann T. Transcranial magnetic brain stimulation: therapeutic promises and scientific gaps. Pharmacol Ther. 2012;133:98-107.
78. Ioannidis JP. Interpretation of tests of heterogeneity and bias in meta-analysis. J Eval Clin Pract. 2008;14:951-957.
79. Machii K, Cohen D, Ramos-Estebanez C, et al. Safety of rTMS to non-motor cortical areas in healthy participants and patients. Clin Neurophysiol. 2006;117:455-471.